LIAISON XL MUREX Control HBsAg Qual

GUDID 28056771500214

DIASORIN S.P.A.

Hepatitis B virus surface antigen IVD, control
Primary Device ID28056771500214
NIH Device Record Keyb4fb3efd-b2eb-4f7e-9539-ac47aff408ab
Commercial Distribution StatusIn Commercial Distribution
Brand NameLIAISON XL MUREX Control HBsAg Qual
Version Model Number318251
Company DUNS216357118
Company NameDIASORIN S.P.A.
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usefalse
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS108056771500210 [Primary]
GS128056771500214 [Package]
Contains: 08056771500210
Package: [20 Units]
In Commercial Distribution

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2021-04-21
Device Publish Date2021-04-13

Devices Manufactured by DIASORIN S.P.A.

18056771500200 - LIAISON XL MUREX HIV Ab/Ag HT2021-05-12
18056771500231 - LIAISON XL MUREX Control HIV Ab/Ag HT2021-05-12
28056771103583 - LIAISON XL MUREX HBsAg Confirmatory 2021-04-21
18056771500187 - LIAISON XL MUREX HBsAg Qual2021-04-21
28056771500214 - LIAISON XL MUREX Control HBsAg Qual2021-04-21
28056771500214 - LIAISON XL MUREX Control HBsAg Qual2021-04-21
08056771500197 - LIAISON® XL MUREX HCV Ab2020-03-04
08056771500227 - LIAISON® XL MUREX Control HCV Ab2020-03-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.